MedPath

Cross-sectional survey on patients experience with suvorexant and other hypnotics in insomnia patients with nocturia

Not Applicable
Conditions
Insomnia with nocturia
Registration Number
JPRN-UMIN000030826
Lead Sponsor
MSD K.K.
Brief Summary

Insomnia symptom that the patient felt most bothersome was nocturnal awakenings in both groups, and the frequency of insomnia symptoms was positively related to the number of nocturnal voids. In the suvorexant group, >=60% of patients answered "satisfied" with the treatment, and there was the relationship between the treatment satisfaction and voiding frequency. In the patients in the other hypnotics group, and there was no association between the treatment satisfaction and the number of nocturnal voids.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
251
Inclusion Criteria

Not provided

Exclusion Criteria

The following disease or symptom: cognitive impairment chronic pain restless leg syndrome sleep related breathing disorder acute urinary tract infection prostate cancer urinary tract cancer

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient experiences with suvorexant including: dosing, frequency of use, symptom relief and satisfaction in insomnia patients with nocturia
Secondary Outcome Measures
NameTimeMethod
Patient experiences with other sleep medications including: dosing, frequency of use, symptom relief and satisfaction in insomnia patients with nocturia
© Copyright 2025. All Rights Reserved by MedPath